Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2019 1
2021 1
2022 1
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Synthesis, Characterization, and Preclinical Evaluation of a Small-Molecule Prostate-Specific Membrane Antigen-Targeted Monomethyl Auristatin E Conjugate.
Machulkin AE, Uspenskaya AA, Zyk NU, Nimenko EA, Ber AP, Petrov SA, Polshakov VI, Shafikov RR, Skvortsov DA, Plotnikova EA, Pankratov AA, Smirnova GB, Borisova YA, Pokrovsky VS, Kolmogorov VS, Vaneev AN, Khudyakov AD, Chepikova OE, Kovalev S, Zamyatnin AA Jr, Erofeev A, Gorelkin P, Beloglazkina EK, Zyk NV, Khazanova ES, Majouga AG. Machulkin AE, et al. Among authors: plotnikova ea. J Med Chem. 2021 Dec 9;64(23):17123-17145. doi: 10.1021/acs.jmedchem.1c01157. Epub 2021 Nov 19. J Med Chem. 2021. PMID: 34797052
Synthesis and biological evaluation of PSMA-targeting paclitaxel conjugates.
Machulkin AE, Skvortsov DA, Ivanenkov YA, Ber AP, Kavalchuk MV, Aladinskaya AV, Uspenskaya AA, Shafikov RR, Plotnikova EA, Yakubovskaya RI, Nimenko EA, Zyk NU, Beloglazkina EK, Zyk NV, Koteliansky VE, Majouga AG. Machulkin AE, et al. Among authors: plotnikova ea. Bioorg Med Chem Lett. 2019 Aug 15;29(16):2229-2235. doi: 10.1016/j.bmcl.2019.06.035. Epub 2019 Jun 20. Bioorg Med Chem Lett. 2019. PMID: 31248772
DR5-Selective TRAIL Variant DR5-B Functionalized with Tumor-Penetrating iRGD Peptide for Enhanced Antitumor Activity against Glioblastoma.
Yagolovich AV, Isakova AA, Artykov AA, Vorontsova YV, Mazur DV, Antipova NV, Pavlyukov MS, Shakhparonov MI, Gileva AM, Markvicheva EA, Plotnikova EA, Pankratov AA, Kirpichnikov MP, Gasparian ME, Dolgikh DA. Yagolovich AV, et al. Among authors: plotnikova ea. Int J Mol Sci. 2022 Oct 21;23(20):12687. doi: 10.3390/ijms232012687. Int J Mol Sci. 2022. PMID: 36293545 Free PMC article.
Synthesis and Investigation of Photophysical and Biological Properties of Novel S-Containing Bacteriopurpurinimides.
Mironov AF, Grin MA, Pantushenko IV, Ostroverkhov PV, Ivanenkov YA, Filkov GI, Plotnikova EA, Karmakova TA, Starovoitova AV, Burmistrova NV, Yuzhakov VV, Romanko YS, Abakumov MA, Ignatova AA, Feofanov AV, Kaplan MA, Yakubovskaya RI, Tsigankov AA, Majouga AG. Mironov AF, et al. Among authors: plotnikova ea. J Med Chem. 2017 Dec 28;60(24):10220-10230. doi: 10.1021/acs.jmedchem.7b00577. Epub 2017 Dec 18. J Med Chem. 2017. PMID: 29202233
Synthesis of Prostate-Specific Membrane Antigen-Targeted Bimodal Conjugates of Cytotoxic Agents and Antiandrogens and Their Comparative Assessment with Monoconjugates.
Zyk NY, Garanina AS, Plotnikova EA, Ber AP, Nimenko EA, Dashkova NS, Uspenskaia AA, Shafikov RR, Skvortsov DA, Petrov SA, Pankratov AA, Zyk NV, Majouga AG, Beloglazkina EK, Machulkin AE. Zyk NY, et al. Among authors: plotnikova ea. Int J Mol Sci. 2023 Jul 11;24(14):11327. doi: 10.3390/ijms241411327. Int J Mol Sci. 2023. PMID: 37511087 Free PMC article.
Dual targeting of DR5 and VEGFR2 molecular pathways by multivalent fusion protein significantly suppresses tumor growth and angiogenesis.
Isakova AA, Artykov AA, Plotnikova EA, Trunova GV, Khokhlova VА, Pankratov AA, Shuvalova ML, Mazur DV, Antipova NV, Shakhparonov MI, Dolgikh DA, Kirpichnikov MP, Gasparian ME, Yagolovich AV. Isakova AA, et al. Among authors: plotnikova ea. Int J Biol Macromol. 2024 Jan;255:128096. doi: 10.1016/j.ijbiomac.2023.128096. Epub 2023 Nov 14. Int J Biol Macromol. 2024. PMID: 37972835
Radiosensitizing effects of heparinized magnetic iron oxide nanoparticles in colon cancer.
Shestovskaya MV, Luss AL, Bezborodova OA, Kulikov PP, Antufrieva DA, Plotnikova EA, Makarov VV, Yudin VS, Pankratov AA, Keskinov AA. Shestovskaya MV, et al. Among authors: plotnikova ea. Biomed Pharmacother. 2024 Jun;175:116668. doi: 10.1016/j.biopha.2024.116668. Epub 2024 May 2. Biomed Pharmacother. 2024. PMID: 38701565 Free article.
Correction: Yagolovich et al. DR5-Selective TRAIL Variant DR5-B Functionalized with Tumor-Penetrating iRGD Peptide for Enhanced Antitumor Activity against Glioblastoma. Int. J. Mol. Sci. 2022, 23, 12687.
Yagolovich AV, Isakova AA, Artykov AA, Vorontsova YV, Mazur DV, Antipova NV, Pavlyukov MS, Shakhparonov MI, Gileva AM, Markvicheva EA, Plotnikova EA, Pankratov AA, Kirpichnikov MP, Gasparian ME, Dolgikh DA. Yagolovich AV, et al. Among authors: plotnikova ea. Int J Mol Sci. 2024 May 14;25(10):5334. doi: 10.3390/ijms25105334. Int J Mol Sci. 2024. PMID: 38791610 Free PMC article.